Triple Agonism Based Therapies for Obesity | Current Cardiovascular Risk Reports US$ 23.60 Min. order: 1 piece ★★★★★ 4.4 (50 reviews) Sold : Login>>
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial US$ 23.70 Min. order: 1 piece ★★★★★ 4.0 (263 reviews) Sold : Login>>